Cover Image

USPSTF Recommendation Against PSA Screening vs. Stage and Cancer‐Specific Mortality in Localized Prostate Cancer

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Fabian Falkenbach, Francesco Di Bello, Natali Rodriguez Peñaranda, Mattia Longoni, Andrea Marmiroli, Quynh Chi Le, Zhe Tian, Jordan A. Goyal, Nicola Longo, Salvatore Micali, Alberto Briganti, Ottavio De Cobelli, Felix K. H. Chun, Fred Saad, Shahrokh F. Shariat, Lars Budäus, Markus Graefen, Pierre I. Karakiewicz
Format:	Artículo Open Access
Published:	Wiley 2025
Subjects:	The Prostate
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Size and SUVmax define the contribution of nodal metastases to PSA in oligorecurrent prostate cancer
by: Fabian Falkenbach, et al.
Published: (2024)

Life Expectancy in High‐Grade Incidental Prostate Cancer Patients Versus Population‐Based Controls According to Treatment Type
by: Francesco Di Bello, et al.
Published: (2024)

Effect of Marital Status on Years of Life Lost From Metastatic Prostate Cancer According to Race/Ethnicity
by: Leonardo Quarta, et al.
Published: (2026)

Reply – Letter to the Editor: Bimodal Imaging at MRI Fusion Prostate Biopsy Will Gain Further Importance in the Future
by: Fabian Falkenbach, et al.
Published: (2025)

Altered Glycosylation of PSA in Prostate Cancer Tissue
by: Hannu Koistinen, et al.
Published: (2025)

Other‐cause mortality in incidental prostate cancer
by: Francesco Di Bello, et al.
Published: (2024)

Beyond Baseline: Serial PSA Measurements and Risk Stratification for Prostate Cancer
by: Anwar E. Ahmed, et al.
Published: (2025)

Bimodal imaging: Detection rate of clinically significant prostate cancer is higher in MRI lesions visible to transrectal ultrasound
by: Fabian Falkenbach, et al.
Published: (2024)

Prostate Volume and PSA‐Density Estimation by Transabdominal Ultrasound: Prospective Evidence of Comparative Accuracy to MRI and Transrectal Ultrasound in Prostate Cancer Early Diagnostics
by: Liza M. Kurucz, et al.
Published: (2025)

A Multimarker Model for Prostate Cancer Risk Assessment: Improving Diagnostic Accuracy Beyond PSA
by: Penglu Yang, et al.
Published: (2025)

Serum Levels of Prostate Specific Antigen, Free PSA, [‐2]proPSA, fPSA/tPSA Ratio, Prostate Health Index, and Glycosylation Patterns of Free PSA in Patients With Benign Prostatic Hyperplasia Pharmacotherapy: Limitations and Future Directions
by: Yitong Weng, et al.
Published: (2025)

Association of Weight Loss and BMI on PSA Levels and Overall Survival in Veterans With Metastatic Castrate‐Resistant Prostate Cancer
by: Nicholas Fedele, et al.
Published: (2025)

Utility of the PROSTest, a Novel Blood‐Based Molecular Assay, Versus PSA for Prostate Cancer Stratification and Detection of Disease
by: Mark Kidd, et al.
Published: (2025)

Surveillance Versus Treatment for Favorable Intermediate‐Risk Prostate Cancer and Mortality‐Risk
by: Mutlay Sayan, et al.
Published: (2026)

Mortality and Additional Treatment Rates in Pathologically High‐Risk Prostate Cancer With Prostate‐Specific Antigen Persistence at Robot‐Assisted Radical Prostatectomy: Long‐Term Report From Single Tertiary Referral Center
by: Alessandro Bertini, et al.
Published: (2025)

Serum levels of prostate specific antigen, free PSA, [−2]proPSA, fPSA/tPSA ratio, Prostate Health Index, and glycosylation patterns of free PSA in patients with benign prostatic hyperplasia pharmacotherapy
by: Michal Jirásko, et al.
Published: (2024)

The Prognostic Significance of Radiographic Progression Without PSA Progression in Patients With Metastatic Hormone‐Sensitive Prostate Cancer Treated With First‐Line ARPI Therapy
by: Takeshi Tsutsumi, et al.
Published: (2026)

The Effects of the Blood‐Based S2,3PSA% Test on Prostate Cancer Screening: A Novel Approach to Reduce the Need for MRI and Unnecessary Biopsies
by: Hikari Miura, et al.
Published: (2025)

Assessment of Circulating Neuroendocrine Tumor Markers at Prostate Cancer Diagnosis: An Investigation of Prostate Cancer With Neuroendocrine Features
by: Tatsuya Shimomura, et al.
Published: (2026)

Evidence and Rationale for Prostate Cancer Screening
by: Takeshi Takahashi
Published: (2025)

Prostate Specific Antigen Density and Clinically‐Significant Prostate Cancer: The Influence of Prostatic Volume
by: Elizabeth Robinson, et al.
Published: (2025)

Castration Resistance Accelerates Prostate Cancer Kinetics
by: Sheila Jonnatan, et al.
Published: (2026)

CHARGE: The “Big Questions” in Prostate Cancer for 2024
by: Andrea K. Miyahira, et al.
Published: (2024)

Predictive Value of PSA Bounce Phenomenon after Stereotactic Body Radiation Therapy in a Large Population of Prostate Cancer Patients Treated By 1.5 T MR Guided Adaptive Technique
by: Andrea Romei, et al.
Published: (2025)

Factors Associated With Male Breast Cancer Incidence Among Prostate Cancer Survivors: Real World Evidence From Veterans Affairs National Prostate Cancer Data Core
by: Erum Z. Whyne, et al.
Published: (2025)

Developments in Ultrasound‐Based Imaging for Prostate Cancer Detection
by: Reid Vassallo, et al.
Published: (2025)

The Diagnostic Value of Plasma Small Extracellular Vesicle‐Derived CAIX Protein in Prostate Cancer and Clinically Significant Prostate Cancer: A Study on Predictive Models
by: Haotian Chen, et al.
Published: (2025)

Diagnostic Performance of the Novel Biomarker S2,3PSA Density for Prostate Biopsy Optimization in Prostate Imaging Reporting and Data System 3–5 Lesions
by: Takanori Tokunaga, et al.
Published: (2025)

Confirmation of BIK and SAMHD1 as Prostate Cancer Susceptibility Genes
by: Christian P. Pavlovich, et al.
Published: (2025)

Spatial Robustness of Prostate Cancer Biomarkers Evaluated by Spatial Transcriptomics
by: Kristofer G. Taylor, et al.
Published: (2026)

Comprehensive Analysis of Fraction of Genome Altered in Prostate Cancer Treatment
by: Muhammad Umair, et al.
Published: (2026)

The Prognostic Value of the Prostate Adenocarcinoma With Ductal Feature in Patients With Advanced Prostate Cancer Treated With Abiraterone Acetate
by: Yifu Shi, et al.
Published: (2025)

Impact of Holmium Laser Enucleation of the Prostate on Active Surveillance for Prostate Cancer in Patients With Lower Urinary Tract Symptoms
by: Charly Bâcle, et al.
Published: (2025)

The Role of Secondary Lesion Biopsy in Detecting Clinically Significant Prostate Cancer
by: Trevor C. Hunt, et al.
Published: (2025)

The 30th Annual Prostate Cancer Foundation Scientific Retreat Report
by: Andrea K. Miyahira, et al.
Published: (2024)

Diagnostic and Prognostic Value of cfDNA Concentration and Fragmentation in Prostate Cancer
by: Marta Victoria Lorenzo‐Sánchez, et al.
Published: (2025)

Androgen Deprivation Therapy: Mitochondrial Dysfunction and Metabolic Impacts in Prostate Cancer
by: Yu‐Hsiang Lin, et al.
Published: (2025)

Enhancing Prostate Cancer Diagnosis: The Combined Value of PHI and mpMRI
by: Y. M. Yáñez‐Castillo, et al.
Published: (2025)

Downregulation of NONO Suppresses Proliferation, Migration, and Invasion in Metastatic Prostate Cancer
by: Anna‐Lena Lemster, et al.
Published: (2025)

Prostate‐Specific Antigen Response at Six Months Predicts Progression in Metastatic Hormone‐Sensitive Prostate Cancer Treated With Apalutamide
by: Christian Andrés Martínez Osorio, et al.
Published: (2025)